| pubmed-article:11735774 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11735774 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11735774 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
| pubmed-article:11735774 | lifeskim:mentions | umls-concept:C0948008 | lld:lifeskim |
| pubmed-article:11735774 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:11735774 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:11735774 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:11735774 | pubmed:dateCreated | 2001-12-12 | lld:pubmed |
| pubmed-article:11735774 | pubmed:abstractText | Intravenous tissue-type plasminogen activator (tPA) therapy using the National Institute of Neurological Disorders and Stroke criteria has been given with variable safety to less than 5% of the patients who have ischemic strokes nationwide. Our center is experienced in treating large numbers of stroke patients with intravenous tPA. | lld:pubmed |
| pubmed-article:11735774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11735774 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11735774 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11735774 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11735774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11735774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11735774 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11735774 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11735774 | pubmed:issn | 0003-9942 | lld:pubmed |
| pubmed-article:11735774 | pubmed:author | pubmed-author:CampbellMM | lld:pubmed |
| pubmed-article:11735774 | pubmed:author | pubmed-author:LongMM | lld:pubmed |
| pubmed-article:11735774 | pubmed:author | pubmed-author:GrottaJ CJC | lld:pubmed |
| pubmed-article:11735774 | pubmed:author | pubmed-author:MorgensternL... | lld:pubmed |
| pubmed-article:11735774 | pubmed:author | pubmed-author:AlexandrovA... | lld:pubmed |
| pubmed-article:11735774 | pubmed:author | pubmed-author:MalkoffMM | lld:pubmed |
| pubmed-article:11735774 | pubmed:author | pubmed-author:BurginW SWS | lld:pubmed |
| pubmed-article:11735774 | pubmed:author | pubmed-author:El-MitwalliAA | lld:pubmed |
| pubmed-article:11735774 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11735774 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:11735774 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11735774 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11735774 | pubmed:pagination | 2009-13 | lld:pubmed |
| pubmed-article:11735774 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:meshHeading | pubmed-meshheading:11735774... | lld:pubmed |
| pubmed-article:11735774 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11735774 | pubmed:articleTitle | Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. | lld:pubmed |
| pubmed-article:11735774 | pubmed:affiliation | Stroke Treatment Team, University of Texas-Houston Medical School, Box 7.044, 6431 Fannin St, Houston, TX 77030, USA. james.c.grotta@uth.tmc.edu | lld:pubmed |
| pubmed-article:11735774 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11735774 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11735774 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11735774 | lld:pubmed |
